Breaking News

CORONAVIRUS

Half of US adults have received at least one COVID-19 shot

WASHINGTON (AP) — Half of all adults in the U.S. have received at least one COVID-19 shot, the government announced Sunday, marking another milestone in the nation's largest-ever vaccination campaign but leaving more work to do to convince skeptical Americans to roll up their sleeves. Almost 130 million people 18 or older have received at least one dose of a vaccine, or 50.4% of the total adult population, the Centers for Disease Control and Prevention reported. Almost 84 million adults, or about 32.5% of the population, have been fully vaccinated. The U.S. cleared the 50% mark ...

US opens more distance in worldwide race against coronavirus

The United States opened more distance between itself and much of the rest of the world Thursday, nearing the 200 millionth vaccine administered in a race to protect the population against COVID-19, even as other countries, rich and poor, struggle with stubbornly high infection rates and deaths. Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% of adults in the U.S. have been fully vaccinated, according to the Centers for Disease Control and Prevention. But the picture is still relentlessly grim in parts of Europe, Latin America, Africa and Asia ...

J&J vaccine to remain in limbo while officials seek evidence

Johnson & Johnson's COVID-19 vaccine will remain in limbo for a while longer after government health advisers declared Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot — and if so, how big the risk really is. The reports are exceedingly rare — six cases out of more than 7 million U.S. inoculations with the one-dose vaccine. But the government recommended a pause in J&J vaccinations this week, not long after European regulators declared that such clots are a rare but possible risk with the AstraZeneca vaccine, a shot made ...

US recommends ‘pause’ for J&J shots in blow to vaccine drive

WASHINGTON (AP) — The U.S. on Tuesday recommended a "pause" in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign. The Centers for Disease Control and Prevention and the Food and Drug Administration announced that they were looking into unusual clots in six women between the ages of 18 and 48. One person died. The acting FDA commissioner expected the pause to last only a matter of days. But the decision ...

Brazil’s virus outlook darkens amid vaccine supply snags

RIO DE JANEIRO (AP) — April is shaping up to be Brazil's darkest month yet in the pandemic, with hospitals struggling with a crush of patients, deaths on track for record highs and few signs of a reprieve from a troubled vaccination program in Latin America's largest nation. The Health Ministry has cut its outlook for vaccine supplies in April three times already, to half their initial level, and the country's two biggest laboratories are facing supply constraints. The delays also mean tens of thousands more deaths as the particularly contagious P.1 variant of COVID-19 sweeps ...

Governments give varying advice on AstraZeneca vaccine

THE HAGUE, Netherlands (AP) — In Spain, residents now have to be over 60 to get an AstraZeneca coronavirus vaccine. In Belgium, over 55. In the United Kingdom, authorities recommend the shot not be given to adults under 30 where possible, and Australia's government announced similar limits Thursday to AstraZeneca shots for those under 50. A patchwork of advice was emerging from governments across Europe and farther afield, a day after the European Union's drug regulator said there was a "possible link" between the AstraZeneca vaccine and a rare clotting disorder while reiterating the ...